PDGF-BB overexpression in p53 null oligodendrocyte progenitors increases H3K27me3 and induces transcriptional changes...

Area of Science:

• Neuro-oncology
• Epigenetics
• Cancer Biology

Background:

• Proneural gliomas are brain tumors originating from oligodendrocyte progenitor cells (OPCs) with specific genetic alterations.
• Understanding the molecular drivers of gliomagenesis is crucial for developing targeted therapies.

Approach:

• Compared transcriptional and epigenetic profiles of genetically modified OPCs: one group with Trp53 deletion and PDGF-BB overexpression (BB-p53n), and another with only p53 deletion (p53n).
• Utilized unbiased histone proteomics and RNA-sequencing (RNA-seq) to analyze differences between these OPC populations.
• Investigated the functional impact of modulating H3K27 trimethylation levels in BB-p53n OPCs.

Key Points:

• BB-p53n OPCs exhibited significantly higher levels of histone H3K27 trimethylation (H3K27me3) compared to p53n OPCs.
• BB-p53n OPCs showed increased expression of proliferation-related genes and decreased expression of differentiation markers.
• Pharmacological inhibition of H3K27 trimethylation in BB-p53n OPCs reversed these effects, reducing proliferation transcripts and enhancing differentiation markers.

Conclusions:

• PDGF-BB overexpression in p53-null OPCs leads to epigenetic alterations, specifically increased H3K27me3.
• These epigenetic changes drive a transcriptional program favoring proliferation and inhibiting differentiation, contributing to early-stage gliomagenesis.
• Targeting H3K27 trimethylation represents a potential therapeutic strategy for proneural gliomas driven by these molecular alterations.